| 中國醫藥大學 |
2003 |
Safety monitoring of cardiac and hepatic systems in beta-thalassemia patients with chelating treatment in Taiwan
|
彭慶添(Ching-Tien Peng); 周寬基(KC Chow); 陳中和(Jeon-Hor Chen); 江宜平(I-Ping Chiang); 林智一(Tze-Yi Lin); 蔡長海(Chang-Hai Tsai) |
| 國立交通大學 |
2014-12-08T15:25:15Z |
Safety Monitoring of the Yellow River Dike Using an Optic Fiber Sensor System
|
Huang Anbin; Ma Jiming; Zhang Baishan; Wen Xiaoguo; Cao Jingang; He Yende |
| 國立交通大學 |
2019-04-02T06:04:43Z |
Safety Monitoring of the Yellow River Dike Using an Optic Fiber Sensor System
|
Huang Anbin; Ma Jiming; Zhang Baishan; Wen Xiaoguo; Cao Jingang; He Yende |
| 朝陽科技大學 |
2025-04-01 |
Safety Monitoring System of Stamping Presses Based on YOLOv8n Model
|
林進發；馮采娜；周郁偉；游禾翔；古耀瑄; Fung, Tsoi-Na; Ku, Yao-Hsuan; Chou, Yu-Wei; Yu, He-Shiang; Lin, Jin-Fa |
| 國立中山大學 |
2002-04 |
Safety Net Design and Implementation in Taiwan Power System
|
T.Y. Hsiao;C.N. Lu;Y.H. Liu;C.L. Cheng;B.S. Chang |
| 臺大學術典藏 |
2021-02-01T00:52:37Z |
Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
|
Chen, Ying-Chou; Yoo, Dae Hyun; Lee, Chang Keun; KO-JEN LI; Won, Ji-Eon; Wu, Wen-Shuo; Zhong, Jinglin; Nicolay, Claudia; Walls, Chad Daniel; Tanaka, Yoshiya |
| 臺大學術典藏 |
2022-02-09T07:42:26Z |
Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
|
Chen, Ying-Chou; Yoo, Dae Hyun; Lee, Chang Keun; KO-JEN LI; Won, Ji-Eon; Wu, Wen-Shuo; Zhong, Jinglin; Nicolay, Claudia; Walls, Chad Daniel; Tanaka, Yoshiya |
| 臺大學術典藏 |
2022-01-25T08:15:19Z |
Safety of baricitinib in East Asian patients with moderate-to-severe active rheumatoid arthritis: An integrated analysis from clinical trials
|
Chen Y.-C.; Yoo D.H.; Lee C.K.; KO-JEN LI; Won J.-E.; Wu W.-S.; Zhong J.; Nicolay C.; Walls C.D.; Tanaka Y. |
| 中山醫學大學 |
2021 |
SAFETY OF BELIMUMAB IN PATIENTS WITH ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS: YEAR 2 FOLLOW-UP OF A LARGE PHASE 4, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
|
Sheikh, S; Scheinberg, M; Wei, JCC; Tegzova, D; Stohl, W; Mucenic, T; Punwaney, R; Kurrasch, R; Harris, J; Muzaffar, S; Fernandes, S; Fox, NL; Liu, A; Quasny, H; Roth, D |
| 國立成功大學 |
2011-08 |
Safety of Cough and Cold Medicines in Children in Taiwan
|
Cheng, Ching-Lan; Kao, Yea-Huei Yang; Lin, Swu-Jane |
| 國立臺灣大學 |
2014 |
Safety of deferasirox: a retrospective cohort study on the risks of gastrointestinal, liver and renal events
|
Huang, Weng-Foung; Chou, Hsin-Chun; Tsai, Yi-Wen; Hsiao, Fei-Yuan; 蕭斐元 |
| 臺大學術典藏 |
2022-09-19T03:17:06Z |
Safety of deferasirox: A retrospective cohort study on the risks of gastrointestinal, liver and renal events
|
Huang W.-F.; Chou H.-C.; Tsai Y.-W.; FEI-YUAN HSIAO |
| 國立臺灣大學 |
2008 |
Safety of Endovascular Recanalization for Symptomatic Cervical Internal Carotid Artery Occlusion
|
林茂欣; 高憲立; LIN, MAO-SHIN; KAO, HSIEN-LI |
| 高雄醫學大學 |
2005 |
Safety of fine-needle aspiration in patients with small hepatocellular carcinoma.
|
王志文;林子堯;莊萬龍;王良彥;余明隆;陳信成;謝明裕;蔡榮發;張文宇 ; Wang CW;Lin ZY;Chuang WL;Wang LY;Yu ML;Chen SC;Hsieh MY;Tsai JF;Chang WY. |
| 國立臺灣大學 |
2009-01 |
SAFETY OF FLUOROQUINOLONE USE IN PATIENTS WITH HEPATOTOXICITY INDUCED BY ANTI-TUBERCULOSIS REGIMENS
|
何肇基; 陳宜君; 胡賦強; 余忠仁; 楊泮池; 陸坤泰; HO, CHAO-CHI; CHEN, YEE-CHUN; HU, FU-CHANG; YU, CHONG-JEN; YANG, PAN-CHYR; LUH, KWEN-TAY |
| 臺大學術典藏 |
2018-09-10T07:19:40Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho, C.-C. and Chen, Y.-C. and Hu, F.-C. and Yu, C.-J. and Yang, P.-C. and Luh, K.-T.; Chong-Jen Yu; CHAO-CHI HO; YEE-CHUN CHEN |
| 臺大學術典藏 |
2020-07-21T06:46:33Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Chen Y.-C.; Hu F.-C.; Yu C.-J.; Yang P.-C.; Luh K.-T.; CHAO-CHI HO |
| 臺大學術典藏 |
2009 |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; YEE-CHUN CHEN; Hu F.-C.; Yu C.-J.; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2020-12-02T02:34:25Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; Pan-Chyr Yang; Luh K.-T.; Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; PAN-CHYR YANG; Luh K.-T. |
| 臺大學術典藏 |
2021-05-06T01:52:34Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; YEE-CHUN CHEN; Hu F.-C.; Yu C.-J.; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2021-05-26T03:34:50Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; Chen Y.-C.; Hu F.-C.; Yu C.-J.; Yang P.-C.; KWEN-TAY LUH |
| 臺大學術典藏 |
2022-06-27T07:07:50Z |
Safety of fluoroquinolone use in patients with hepatotoxicity induced by anti-tuberculosis regimens
|
Ho C.-C.; Chen Y.-C.; Hu F.-C.; CHONG-JEN YU; Yang P.-C.; Luh K.-T. |
| 臺大學術典藏 |
2018-09-10T15:34:00Z |
Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study
|
Prince, M.R. and Lee, H.G. and Lee, C.-H. and Youn, S.W. and Lee, I.H. and Yoon, W. and Yang, B. and Wang, H. and Wang, J. and Shih, T.T.-F. and Huang, G.-S. and Lirng, J.-F. and Palkowitsch, P. and On Behalf Of The Gardian Study Group; TIFFANY TING-FANG SHIH |
| 臺大學術典藏 |
2020-08-06T07:51:45Z |
Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study
|
Prince M.R.;Lee H.G.;Lee C.-H.;Youn S.W.;Lee I.H.;Yoon W.;Yang B.;Wang H.;Wang J.;Tiffany Ting-Fang Shih;Huang G.-S.;Lirng J.-F.;Palkowitsch P.;On Behalf Of The Gardian Study Group; Prince M.R.; Lee H.G.; Lee C.-H.; Youn S.W.; Lee I.H.; Yoon W.; Yang B.; Wang H.; Wang J.; TIFFANY TING-FANG SHIH; Huang G.-S.; Lirng J.-F.; Palkowitsch P.; on behalf of the GARDIAN study group |
| 臺大學術典藏 |
2020-05-26T09:26:45Z |
Safety of gefitinib in non-small cell lung cancer treatment
|
Chih-Hsin Yang;Lin C.-C;Lee J.-H;Hsiue E.H.-C; Hsiue E.H.-C; Lee J.-H; Lin C.-C; CHIH-HSIN YANG |
